SPECIAL REPORT The Top 7 Stocks for 2024

Dear LUNR Stock Fans, Mark Your Calendars for Jan. 12

Advertisement

  • Intuitive Machines (LUNR) stock is rising ahead of a catalyst on Jan 12.
  • That’s when a window opens to launch its lunar mission.
  • This has investors excited about its potential moon trip.
LUNR Stock - Dear LUNR Stock Fans, Mark Your Calendars for Jan. 12

Source: shutterstock.com/T. Schneider

Intuitive Machines (NASDAQ:LUNR) stock fans will want to mark their calendars for Jan. 12, 2024 as the company prepares for a major catalyst.

That date marks the opening of a window for the liftoff of the company’s IM-1 lunar mission. The multi-day launch window gives the company’s partner, SpaceX, time to ensure good conditions for the launch of the company’s lunar mission.

Investors will note that this mission will be the first attempt by Intuitive Machines to land on the moon. This follows the completion of its lunar lander in September. The company is launching this mission under NASA’s Commercial Lunar Payload Services, which is part of its Artemis lunar exploration plans.

Steve Altemus, co-founder, President and CEO of Intuitive Machines, said the following about the news:

“There are inherent challenges of lunar missions; schedule changes and mission adjustments are a natural consequence of pioneering lunar exploration. Receiving a launch window and the required approvals to fly is a remarkable achievement, and the schedule adjustment is a small price to pay for making history.”

How This Affects LUNR Stock

Investors are excited about the prospect of the company completing a lunar mission next year. That has its shares already rising 5.2% as of Monday morning. If it all goes well on Jan. 12, it could result in LUNR stock seeing even greater gains as it reaps the rewards of its hard work.

Investors looking for more of the hottest stock market news today are in the right place!

InvestorPlace is home to all of the biggest stock market stories worth reading about on Monday! Among that is what’s happening with shares of Medicenna Therapeutics (NASDAQ:MDNA), Nuvve (NASDAQ:NVVE) and Conduit Pharmaceuticals (NASDAQ:CDT) stock today. All of that news is ready to go down below!

More Monday Stock Market News

On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks. 

Read More:Penny Stocks — How to Profit Without Getting Scammed

On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.


Article printed from InvestorPlace Media, https://investorplace.com/2023/10/dear-lunr-stock-fans-mark-your-calendars-for-jan-12/.

©2024 InvestorPlace Media, LLC